Context and challenges
This client is a world-wide biotechnology company. One of its sites is a new biological manufacturing facility, located in Luterbach near Solothurn. Production is to start in 2019 to be fully operational in 2020.
This plant will support the manufacture of mammalian cell culture products in bio-manufacturing production units.
Firstly, two bio-manufacturing production units are planned to be built. The site Master Plan allows for up to seven units to be built. Each building has all the required equipment (upstream and downstream, support and utilities) for the production of biopharmaceutical drug substances.
Additional facilities on the Solothurn site will include a warehouse with manufacturing support, QC (Qualification and Commissioning) laboratory, administration facilities, tank farm and a Central Utilities Building (CUB).
During the construction phase, this client appointed Assystem Care to implement an industrial maintenance strategy, including a strategy for integrated facility management organisation.